Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.23 (
beta-galactosidase
)
14,648
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Delivering cytoprotective proteins/peptides into pancreata prior to islet isolation through protein transduction (PT) is a novel strategy to enhance the yield of viable transplantable islets. Previous work has shown that the protein transduction domain
PTD
-5 efficiently transduced islets via the pancreatic duct. TAT/
PTD
is a well-characterized
PTD
with the capability to cross even the hemato-encephalic barrier. In this study, we investigated the utilization of the 11-aa TAT protein transduction domain (TAT/
PTD
) to deliver peptides or proteins of different sizes ranging from 1.2 to 120 kDa, as the TAT/
PTD
and TAT/
PTD
-BH4 peptide, or the TAT/
PTD
-
beta-galactosidase
fusion protein, into islets through the pancreatic duct. Using flow cytometry analysis we found that TAT/
PTD
derivatives transduced practically 100% of the islet cell population. Moreover, confocal laser scanning microscopy in live, nonfixed islets confirmed these results assessing transduction of TAT/
PTD
molecules into intact nondisaggregated islets. TAT-
beta-galactosidase
peptide conjugated to FITC was not compartment selective, as both cytoplasmic and nucleic cellular compartments were positively stained. Furthermore, TAT-
beta-galactosidase
peptide delivery was highly effective, as even cells located in the inner core region of the islets were transduced. Finally, transduced TAT-
beta-galactosidase
fusion protein was biologically active after islet isolation and manipulation, and islet insulin secretion capability was not compromised by peptide transduction. These findings suggest that the transduction of chimeric TAT/
PTD
proteins can represent an efficient tool of molecular delivery independent of the size, to enhance or modify a specific phenotype at the nuclei or cytoplasmic level.
...
PMID:Delivery of TAT/PTD-fused proteins/peptides to islets via pancreatic duct. 1605 6